How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?

How many times should we repeat measurements of the ultrasound-guided attenuation parameter for evaluating hepatic steatosis?

Purpose This retrospective study aimed to determine the number of times the ultrasound-guided attenuation parameter (UGAP) should be measured during the evaluation of hepatic steatosis. Methods Patients with suspected nonalcoholic fatty liver disease who underwent two UGAP repetition protocols (six-...

Full description

Bibliographic Details
Main Authors:	Duck Min Seo, Sang Min Lee, Ji Won Park, Min-Jeong Kim, Hong Il Ha, Sun-Young Park, Kwanseop Lee
Format:	Article
Language:	English
Published:	Korean Society of Ultrasound in Medicine 2023-04-01
Series:	Ultrasonography
Subjects:	fatty liver nonalcoholic fatty liver disease diagnostic imaging ultrasonography
Online Access:	http://www.e-ultrasonography.org/upload/usg-22122.pdf

Similar Items

Inter-platform reproducibility of ultrasound-based fat fraction for evaluating hepatic steatosis in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2024-02-01)

Assessment of the inter-platform reproducibility of ultrasound attenuation examination in nonalcoholic fatty liver disease
by: Sun Kyung Jeon, et al.
Published: (2022-04-01)

Accuracy of attenuation imaging in the assessment of pediatric hepatic steatosis: correlation with the controlled attenuation parameter
by: Pyeong Hwa Kim, et al.
Published: (2022-10-01)

Quantitative ultrasound radiofrequency data analysis for the assessment of hepatic steatosis using the controlled attenuation parameter as a reference standard
by: Sun Kyung Jeon, et al.
Published: (2021-01-01)

Reproducibility of ultrasound attenuation imaging for the noninvasive evaluation of hepatic steatosis
by: Jeongin Yoo, et al.
Published: (2020-04-01)

Correlational study of nonalcoholic fatty liver disease diagnosed by ultrasonography with lipid profile and body mass index in adult nepalese population
by: Umesh P Khanal, et al.
Published: (2019-01-01)

Ultrasound-Guided Attenuation Parameter May Replace B-mode Ultrasound in Diagnosing Nonalcoholic Fatty Liver Disease
by: Bo Jiang, MD, Yiman Du, MD, Xiang Fei, MD, Jianing Zhu, MD, Lianhua Zhu, MD, Qiuyang Li, MD, Yukun Luo, MD, PhD
Published: (2023-09-01)

Noninvasive assessment of hepatic steatosis using a pathologic reference standard: comparison of CT, MRI, and US-based techniques
by: Jae Seok Bae, et al.
Published: (2022-04-01)

Hyperechoic pancreas on ultrasonography: an analysis of its severity and clinical implications
by: Hyunji Oh, et al.
Published: (2022-04-01)

Association between hepatic steatosis and the development of hepatocellular carcinoma in patients with chronic hepatitis B
by: Yun Bin Lee, et al.
Published: (2019-03-01)

Comparison of liver enzymes and sonological grading in nonalcoholic fatty liver
by: Bishnu Jwarchan, et al.
Published: (2020-03-01)

The association of hepatic steatosis and fibrosis with heart failure and mortality
by: Jiyun Park, et al.
Published: (2021-09-01)

Modifications decrease hepatic steatosis in Taiwanese with metabolic‐associated fatty liver disease
by: Tso‐Tsai Liu, et al.
Published: (2022-10-01)

Correlation of the grade of hepatic steatosis between controlled attenuation parameter and ultrasound in patients with fatty liver: a multi-center retrospective cohort study
by: Jeong-Ju Yoo, et al.
Published: (2020-11-01)

Honokiol Improves Liver Steatosis in Ovariectomized Mice
by: Yeon-Hui Jeong, et al.
Published: (2018-01-01)

Severity of hyperechoic pancreas on ultrasonography as a risk factor for glycemic progression
by: Jiyun Oh, et al.
Published: (2021-10-01)

Accuracy of the ultrasound attenuation coefficient for the evaluation of hepatic steatosis: a systematic review and meta-analysis of prospective studies
by: Jong Keon Jang, et al.
Published: (2022-01-01)

Noninvasive serum biomarkers for liver steatosis in nonalcoholic fatty liver disease: Current and future developments
by: Sang Bong Ahn
Published: (2023-02-01)

Hepatic enzyme concentrations as indicators of nonalcoholic fatty liver disease
by: Alvina Alvina
Published: (2016-02-01)

Non-alcoholic fatty liver disease: A review with clinical and pathological correlation
by: Yen-Ying Chen, et al.
Published: (2021-01-01)

Value of screening for nonalcoholic fatty liver disease in hyperuricemic patients with normal body mass index by two-dimensional ultrasound: Upper Egypt experience
by: Amro M Hassan, et al.
Published: (2020-01-01)

US Attenuation Imaging for the Evaluation and Diagnosis of Fatty Liver Disease
by: Seung Jun Lee, et al.
Published: (2023-05-01)

Influence of pancreatic steatosis severity on the course of pediatric nonalcoholic fatty pancreas disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01)

Examining genetic associations with hepatic steatosis in Mexican-origin adults
by: Mario Jesus Trejo, et al.
Published: (2023-09-01)

Free fatty acid-based low-impedance liver image: a characteristic appearance in nonalcoholic steatohepatitis (NASH)
by: Hitoshi Maruyama, et al.
Published: (2020-01-01)

Predictors of nonalcoholic fatty liver disease among middle-aged Iranians
by: Reza Etminani, et al.
Published: (2020-01-01)

Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis
by: Jinwang Li, et al.
Published: (2021-12-01)

Does Nonalcoholic Pancreatic Steatosis Always Correlate with Nonalcoholic Fatty Liver Disease?
by: Ulasoglu C, et al.
Published: (2021-06-01)

Multiple MicroRNAs Ameliorate Hepatocyte Steatosis and Injury by Suppressing FABP1 Expression
by: Yun-li Wu, et al.
Published: (2017-12-01)

Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
by: Yu-ling Chen, et al.
Published: (2021-05-01)

Genetic determinants of hepatic steatosis in man
by: Amanda J. Hooper, et al.
Published: (2011-04-01)

Serum bilirubin levels are inversely associated with nonalcoholic fatty liver disease
by: Min-Sun Kwak, et al.
Published: (2012-12-01)

Alterations in Cytoskeleton and Mitochondria in the Development and Reversal of Steatosis in Human HepatocytesSummary
by: Letao Fan, et al.
Published: (2023-01-01)

A randomized double-blind study of the short-time treatment of obese patients with nonalcoholic fatty liver disease with ursodeoxycholic acid
by: V.N. Santos, et al.
Published: (2003-06-01)

Nonalcoholic Fatty Liver Disease Is a Precursor of New-Onset Metabolic Syndrome in Metabolically Healthy Young Adults
by: Jeong-Ju Yoo, et al.
Published: (2022-02-01)

Dietary inflammatory index in relation to the progression of hepatic steatosis and liver fibrosis: evaluation by elastography/Fibroscan
by: Mahsa Miryan, et al.
Published: (2024-04-01)

Ultrasound Stratification of Hepatic Steatosis Using Hepatorenal Index
by: Stephen I. Johnson, et al.
Published: (2021-08-01)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatotic Liver Disease with Increased Alcohol Intake Increase the Risk of Developing Hepatocellular Carcinoma and Incident or Decompensated Cirrhosis: A Korean Nationwide Study
by: Gi-Ae Kim, et al.
Published: (2023-12-01)

Multifocal fatty liver nodules mimicking a metastatic disease: A case report
by: Huy Quang Duong, et al.
Published: (2024-03-01)

Identification of key genes and pathways in mild and severe nonalcoholic fatty liver disease by integrative analysis
by: Jin Feng, et al.
Published: (2021-12-01)